2025-2034 Bioprocess Automation Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Bioprocess Automation Market Through 2025?
The scale of the bioprocess automation market has seen a swift expansion in the past few years. The market value is projected to surge from $5.67 billion in 2024 to $6.37 billion in 2025, delivering a compound annual growth rate (CAGR) of 12.2%. The historical period's growth can be traced back to enhanced efficiency, cost-cutting, risk management, a surging need for remote monitoring and control, and diminished reliance on labor.

What's the Projected Size of the Global Bioprocess Automation Market by 2029?
In the coming years, the bioprocess automation market is projected to experience a swift expansion. Its size is predicted to reach $10.27 billion in 2029, representing a compound annual growth rate (CAGR) of 12.7%. The reasons for this surge during the forecast period are improved productivity, regulatory adherence, process refinement, predictive upkeep, and instant analytics. Additionally, the forecast period will also witness major trends like the incorporation of AI and machine learning, modular bioprocessing techniques, process control strategies applicable to gene therapy, alongside data analytics and visualization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Top Growth Drivers in the Bioprocess Automation Industry: What's Accelerating the Market?
The growth of the bioprocess automation market is anticipated to be accelerated by the rising number of personalized medicines. Personalized medicine is an approach to healthcare that adjusts decisions, practices, interventions, and therapy to the unique characteristics of each patient. Bioprocess automation industry benefits personalized medicine by providing precision and scalability in the production of patient-specific drugs. For example, the Personalized Medicine Coalition, a professional membership organization based in the US, reported that in 2022, the approval of 12 new personalized medicines constituted approximately 34% of all newly approved treatments, marking a significant increase from past years. Therefore, the proliferating number of personalized medicines is propelling the bioprocess automation market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14058&type=smp

What Trends Will Shape the Bioprocess Automation Market Through 2029 and Beyond?
Leading businesses in the bioprocess automation market, such as Cytiva, are creating cutting-edge solutions, like bioreactors, to streamline bioprocessing procedures. A bioreactor provides a controlled and ideal setting for biological and chemical reactions. In April 2023, Cytiva, a technology firm from the United States specializing in advancing and speeding up the production and development of therapeutics, introduced X-platform bioreactors to simplify single-use upstream bioprocessing procedures. These bioreactors, initially available in 50 and 200 L capacities, are easy to use, adaptable, and enhance process efficiency. They boost efficiency by improving ergonomics, manufacturing capacity, and streamlining supply chain processes. The X-platform bioreactors have applications in the production of cell and gene therapies, viral vectors, and monoclonal antibodies (mAbs).

What Are the Main Segments in the Bioprocess Automation Market?
The bioprocess automation market covered in this report is segmented -

1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems

Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14058&type=smp

Which Top Companies are Driving Growth in the Bioprocess Automation Market?
Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA, Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG, Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.

Which Regions Will Dominate the Bioprocess Automation Market Through 2029?
North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14058

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.